BioTime names Adi Mohanty COO
This article was originally published in Scrip
Executive Summary
Californian pluripotent stem cell therapy developer BioTime has appointed Adi Mohanty chief operating officer, reporting to CEO Dr Michael West. Mr Mohanty previously worked at Shire in a variety of leadership positions, most recently as head of the Regenerative Medicine Business.